Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115054
Chunk: 7

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 7
---
 possible methods of sale that may be used by the Selling Securityholder, you should refer to the section of this prospectus titled “Plan of Distribution” beginning on page 258 of this prospectus. We will not receive any proceeds from the resale of any of the Resale Shares being registered hereby sold by the Selling Securityholder. We will, however, receive the proceeds from the exercise of the Deposit Warrant. No underwriter or other person has been engaged to facilitate the sale of the shares of the Resale Shares. The Selling Securityholder may be deemed to be an “underwriter” within the meaning of the Securities Act, of the Resale Shares that it is offering pursuant to this prospectus. We will bear all costs, expenses and fees in connection with the registration of the Resale Shares. The Selling Securityholder will bear all commissions and discounts, if any, attributable to its sales of the Resale Shares.

Our Common Stock is listed on the Nasdaq Capital Market under the symbol “SCLX”. On May 5, 2025, the last reported sales price per share of our Common Stock was $5.43.

On April 15, 2025, we effected a reverse stock split of our Common Stock at a ratio of 1-for-35 (the “Reverse Stock Split”). Unless otherwise noted, the share and per share information in this prospectus reflects the effect of the Reverse Stock Split. The Company’s historical financial statements included in this prospectus do not reflect the Reverse Stock Split.

We are an “emerging growth company” as that term is used in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings with the Securities and Exchange Commission.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this prospectus, together with additional information described under the heading “Where You Can Find More Information”, and any amendments or supplements carefully before you invest in any of our securities.

INVESTING IN OUR COMMON STOCK INVOLVES SUBSTANTIAL RISKS. YOU SHOULD REVIEW CAREFULLY THE RISKS AND UNCERTAINTIES DESCRIBED UNDER THE HEADING “RISK FACTORS” BEGINNING ON PAGE 23 OF THIS PROSPECTUS.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or